Logo image of CHG.DE

CHAPTERS GROUP AG (CHG.DE) Stock Fundamental Analysis

FRA:CHG - Deutsche Boerse Ag - DE0006618309 - Common Stock - Currency: EUR

29.2  -0.6 (-2.01%)

Fundamental Rating

3

Overall CHG gets a fundamental rating of 3 out of 10. We evaluated CHG against 50 industry peers in the Financial Services industry. CHG may be in some trouble as it scores bad on both profitability and health. CHG is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

CHG had negative earnings in the past year.
In the past year CHG had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: CHG reported negative net income in multiple years.
CHG had negative operating cash flow in 4 of the past 5 years.
CHG.DE Yearly Net Income VS EBIT VS OCF VS FCFCHG.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5M -5M 10M

1.2 Ratios

CHG's Return On Assets of -3.10% is on the low side compared to the rest of the industry. CHG is outperformed by 80.00% of its industry peers.
CHG has a worse Return On Equity (-5.54%) than 78.00% of its industry peers.
Industry RankSector Rank
ROA -3.1%
ROE -5.54%
ROIC N/A
ROA(3y)-1.36%
ROA(5y)-9.09%
ROE(3y)-1.95%
ROE(5y)-11.98%
ROIC(3y)N/A
ROIC(5y)N/A
CHG.DE Yearly ROA, ROE, ROICCHG.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50

1.3 Margins

With an excellent Gross Margin value of 80.66%, CHG belongs to the best of the industry, outperforming 82.00% of the companies in the same industry.
CHG's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for CHG so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 80.66%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-5.44%
CHG.DE Yearly Profit, Operating, Gross MarginsCHG.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20K -20K 40K -40K 60K

2

2. Health

2.1 Basic Checks

CHG does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CHG has more shares outstanding
Compared to 5 years ago, CHG has more shares outstanding
Compared to 1 year ago, CHG has a worse debt to assets ratio.
CHG.DE Yearly Shares OutstandingCHG.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M
CHG.DE Yearly Total Debt VS Total AssetsCHG.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M

2.2 Solvency

CHG has an Altman-Z score of 2.97. This is not the best score and indicates that CHG is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of CHG (2.97) is better than 70.00% of its industry peers.
CHG has a debt to FCF ratio of 6.46. This is a slightly negative value and a sign of low solvency as CHG would need 6.46 years to pay back of all of its debts.
CHG has a Debt to FCF ratio of 6.46. This is comparable to the rest of the industry: CHG outperforms 52.00% of its industry peers.
A Debt/Equity ratio of 0.17 indicates that CHG is not too dependend on debt financing.
CHG has a Debt to Equity ratio of 0.17. This is in the better half of the industry: CHG outperforms 72.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF 6.46
Altman-Z 2.97
ROIC/WACCN/A
WACC6.86%
CHG.DE Yearly LT Debt VS Equity VS FCFCHG.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

2.3 Liquidity

A Current Ratio of 0.70 indicates that CHG may have some problems paying its short term obligations.
CHG has a worse Current ratio (0.70) than 72.00% of its industry peers.
CHG has a Quick Ratio of 0.70. This is a bad value and indicates that CHG is not financially healthy enough and could expect problems in meeting its short term obligations.
CHG has a worse Quick ratio (0.65) than 72.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.7
Quick Ratio 0.65
CHG.DE Yearly Current Assets VS Current LiabilitesCHG.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M

7

3. Growth

3.1 Past

CHG shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 4.70%.
Looking at the last year, CHG shows a very strong growth in Revenue. The Revenue has grown by 158.74%.
CHG shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 93.11% yearly.
EPS 1Y (TTM)4.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-18.88%
Revenue 1Y (TTM)158.74%
Revenue growth 3Y303.43%
Revenue growth 5Y93.11%
Sales Q2Q%48.63%

3.2 Future

The Earnings Per Share is expected to grow by 416.76% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 32.75% on average over the next years. This is a very strong growth
EPS Next Y3700%
EPS Next 2Y794.43%
EPS Next 3Y416.77%
EPS Next 5YN/A
Revenue Next Year56.5%
Revenue Next 2Y42.64%
Revenue Next 3Y32.75%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
CHG.DE Yearly Revenue VS EstimatesCHG.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 50M 100M 150M
CHG.DE Yearly EPS VS EstimatesCHG.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.2 0.4 0.6 0.8 1

2

4. Valuation

4.1 Price/Earnings Ratio

CHG reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
CHG is valuated quite expensively with a Price/Forward Earnings ratio of 37.07.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CHG indicates a slightly more expensive valuation: CHG is more expensive than 64.00% of the companies listed in the same industry.
CHG's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.10.
Industry RankSector Rank
PE N/A
Fwd PE 37.07
CHG.DE Price Earnings VS Forward Price EarningsCHG.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60

4.2 Price Multiples

CHG's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. CHG is more expensive than 64.00% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CHG indicates a slightly more expensive valuation: CHG is more expensive than 68.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 51.64
EV/EBITDA 73.71
CHG.DE Per share dataCHG.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CHG's earnings are expected to grow with 416.76% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y794.43%
EPS Next 3Y416.77%

0

5. Dividend

5.1 Amount

CHG does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CHAPTERS GROUP AG

FRA:CHG (3/7/2025, 7:00:00 PM)

29.2

-0.6 (-2.01%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)05-24 2024-05-24
Earnings (Next)N/A N/A
Inst Owners8.85%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap570.86M
Analysts80
Price Target34.68 (18.77%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)21.43%
PT rev (3m)21.43%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 37.07
P/S 6.55
P/FCF 51.64
P/OCF 36.83
P/B 3.9
P/tB 57.67
EV/EBITDA 73.71
EPS(TTM)-0.41
EYN/A
EPS(NY)0.79
Fwd EY2.7%
FCF(TTM)0.57
FCFY1.94%
OCF(TTM)0.79
OCFY2.71%
SpS4.46
BVpS7.49
TBVpS0.51
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.1%
ROE -5.54%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 80.66%
FCFM 12.69%
ROA(3y)-1.36%
ROA(5y)-9.09%
ROE(3y)-1.95%
ROE(5y)-11.98%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-5.44%
F-Score7
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF 6.46
Debt/EBITDA 3.18
Cap/Depr 28.42%
Cap/Sales 5.1%
Interest Coverage N/A
Cash Conversion 197.34%
Profit Quality N/A
Current Ratio 0.7
Quick Ratio 0.65
Altman-Z 2.97
F-Score7
WACC6.86%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-18.88%
EPS Next Y3700%
EPS Next 2Y794.43%
EPS Next 3Y416.77%
EPS Next 5YN/A
Revenue 1Y (TTM)158.74%
Revenue growth 3Y303.43%
Revenue growth 5Y93.11%
Sales Q2Q%48.63%
Revenue Next Year56.5%
Revenue Next 2Y42.64%
Revenue Next 3Y32.75%
Revenue Next 5YN/A
EBIT growth 1Y-599.15%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year8233.33%
EBIT Next 3Y440.23%
EBIT Next 5Y188.53%
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A